|
| | Geneesmiddel: | mesalazine , sulfasalazine
| | Auteurs: | R A J Ransford and M J S Langman | | Publicatie: | Gut | | Publicatiedatum: | Gut 2002;51:536-539 | | Extra info: | Spontaneous reports suggest that within the five sets of disorders considered, there is no evidence to indicate a safety advantage of mesalazine over sulphasalazine in the treatment of inflammatory bowel disease. Pancreatitis and interstitial nephritis appear significantly more common with mesalazine, and advice on renal monitoring in patients who receive mesalazine may need reinforcing. | | Trefwoorden: | pancreatitis, interstitiële nefritis, sulfasalzine | | gut.bmjjournals.com/cgi/content/abstract/51/4/536? - 27 feb 2005 |
|
|
